Abstract
This invention features an antibody specifically binding to human IL-20 (e.g., mAb 7E and a equivalent thereof) and its use in treating an IL-20 associated inflammatory disease, such as atherosclerosis, RA, psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure
| Translated title of the contribution | Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases |
|---|---|
| Original language | English |
| Patent number | 7786274 |
| Publication status | Published - 2009 Feb 19 |
